These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 2947680)

  • 1. Phase II trial of streptozocin in the treatment of advanced renal cell carcinoma.
    Licht JD; Garnick MB
    Cancer Treat Rep; 1987 Jan; 71(1):97-8. PubMed ID: 2947680
    [No Abstract]   [Full Text] [Related]  

  • 2. Phase II trial of elliptinium in advanced renal cell carcinoma.
    Caillé P; Mondesir JM; Droz JP; Kerbrat P; Goodman A; Ducret JP; Theodore C; Spielman M; Rouëssé J; Amiel JL
    Cancer Treat Rep; 1985; 69(7-8):901-2. PubMed ID: 4016798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II evaluation of mitoxantrone in advanced renal cell carcinoma: a Southeastern Cancer Study Group Trial.
    Gams RA; Nelson O; Birch R
    Cancer Treat Rep; 1986 Jul; 70(7):921-2. PubMed ID: 3521848
    [No Abstract]   [Full Text] [Related]  

  • 4. Phase II evaluation of chlorozotocin in patients with renal cell carcinoma.
    Gralla RJ; Yagoda A
    Cancer Treat Rep; 1979 Jun; 63(6):1007-8. PubMed ID: 157222
    [No Abstract]   [Full Text] [Related]  

  • 5. Phase II trial of 1,2,4-triglycidylurazol in patients with metastasized renal cell carcinoma.
    Wagner H; Possinger K; Bremer K; Donhujsen-Ant R; Peukert M; Queisser W
    Cancer Treat Rep; 1987 Feb; 71(2):209-10. PubMed ID: 3802118
    [No Abstract]   [Full Text] [Related]  

  • 6. [Medical treatment of metastatic cancer of the kidney with a combination of vinblastine and recombinant interferon alpha IIa. Result of a phase I-II trial].
    Jacqmin D; Bergerat JP; Dufour P; Bollack C; Prévot G; Jurascheck F; Bailly G; Degaris S; Oberling F
    J Urol (Paris); 1987; 93(8):463-6. PubMed ID: 3440838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II study of thymosin fraction 5 in the treatment of metastatic renal cell carcinoma.
    Dimitrov NV; Arnold D; Munson J; Singh T; Borst J; Stott P
    Cancer Treat Rep; 1985 Jan; 69(1):137-8. PubMed ID: 3967256
    [No Abstract]   [Full Text] [Related]  

  • 8. Phase II evaluation of chlorozotocin in advanced bronchogenic carcinoma.
    Creagan ET; Eagan RT; Fleming TR; Frytak S; Kvols LK; Ingle JN
    Cancer Treat Rep; 1979; 63(11-12):2105-6. PubMed ID: 230898
    [No Abstract]   [Full Text] [Related]  

  • 9. Phase II trial of 10-deazaaminopterin for advanced hypernephroma.
    Scher HI; Yagoda A; Ahmed T; Hollander P; Watson RC
    Anticancer Res; 1984; 4(6):409-10. PubMed ID: 6517533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapy for advanced renal cell cancer with spirogermanium: a Southwest Oncology Group Study.
    Saiers JH; Slavik M; Stephens RL; Crawford ED
    Cancer Treat Rep; 1987 Feb; 71(2):207-8. PubMed ID: 3802117
    [No Abstract]   [Full Text] [Related]  

  • 11. Phase II studies of PCNU and bisantrene in advanced renal cell carcinoma.
    Elson PJ; Earhart RH; Kvols LK; Spiegel R; Keller AM; Kies MS; Davis TE; Stevens C; Gumas L; Trump DL
    Cancer Treat Rep; 1987 Mar; 71(3):331-2. PubMed ID: 3815401
    [No Abstract]   [Full Text] [Related]  

  • 12. Of snails and holy grails..
    Yang JC
    Cancer J Sci Am; 1997; 3(3):142-3. PubMed ID: 9161778
    [No Abstract]   [Full Text] [Related]  

  • 13. A phase II trial of interferon-alpha and 5-fluorouracil in patients with advanced renal cell carcinoma. A Southwest Oncology Group study.
    Elias L; Blumenstein BA; Kish J; Flanigan RC; Wade JL; Lowe BA; Goodwin JW; Crawford ED
    Cancer; 1996 Sep; 78(5):1085-8. PubMed ID: 8780547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II study of troxacitabine (BCH-4556) in patients with advanced and/or metastatic renal cell carcinoma: a trial of the National Cancer Institute of Canada-Clinical Trials Group.
    Townsley CA; Chi K; Ernst DS; Belanger K; Tannock I; Bjarnason GA; Stewart D; Goel R; Ruether JD; Siu LL; Jolivet J; McIntosh L; Seymour L; Moore MJ;
    J Clin Oncol; 2003 Apr; 21(8):1524-9. PubMed ID: 12697876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The phase I and early phase II studies of human lymphoblast interferon (MOR-22) in the treatment of malignant tumors].
    Tsubura E
    Nihon Gan Chiryo Gakkai Shi; 1986 Jun; 21(5):1049-58. PubMed ID: 3463630
    [No Abstract]   [Full Text] [Related]  

  • 16. Phase II study of lonidamine in patients with metastatic renal cell carcinoma: a National Cancer Institute of Canada Clinical Trials Group Study.
    Weinerman BH; Eisenhauer EA; Besner JG; Coppin CM; Stewart D; Band PR
    Cancer Treat Rep; 1986 Jun; 70(6):751-4. PubMed ID: 3524824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II trial of combination interferon-alpha and thalidomide as first-line therapy in metastatic renal cell carcinoma.
    Clark PE; Hall MC; Miller A; Ridenhour KP; Stindt D; Lovato JF; Patton SE; Brinkley W; Das S; Torti FM
    Urology; 2004 Jun; 63(6):1061-5. PubMed ID: 15183950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neocarzinostatin therapy of advanced renal cell carcinoma].
    Tari K; Satake I; Kojima S; Tsujii T; Yonese J
    Gan To Kagaku Ryoho; 1988 Sep; 15(9):2719-23. PubMed ID: 2970825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase II study of flavopiridol in patients with advanced renal cell carcinoma: results of Southwest Oncology Group Trial 0109.
    Van Veldhuizen PJ; Faulkner JR; Lara PN; Gumerlock PH; Goodwin JW; Dakhil SR; Gross HM; Flanigan RC; Crawford ED;
    Cancer Chemother Pharmacol; 2005 Jul; 56(1):39-45. PubMed ID: 15791454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II trial of recombinant interferon alpha-2C in metastatic renal cell carcinoma.
    Scheithauer W; Kuehrer I; Kutzmits R; Dittrich C; Steger G; Flener R; Ludwig H
    J Biol Regul Homeost Agents; 1987; 1(2):81-6. PubMed ID: 3504086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.